How many insider trades does FilingIQ track for IMUX?

FilingIQ tracks 40 Form 4 insider transactions for IMUX (IMMUNIC, INC.), covering filings from Dec 2, 2019 onwards. 2 of those were filed in the last 90 days.

Are IMUX insiders net buyers or net sellers?

Across the full Form 4 history for IMUX, 29 transactions (73%) were open-market purchases and 5 (13%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does IMUX insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is IMUX in?

IMMUNIC, INC. (IMUX) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $203.91M.

IMUX insider trading

NasdaqCM Healthcare

IMMUNIC, INC. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

Last 90 days

Buys / sells

73% / 13%

Market cap

$203.91M

About IMMUNIC, INC.

Immunic, Inc., a biotechnology company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases in the United States and Germany. Its lead development program is IMU-838, which is in Phase 3 clinical and phase 2 clinical development for patients with relapsing and progressive multiple sclerosis; and moderate-to-severe ulcerative colitis. The company also develops IMU-856, which is entering Phase 2 clinical trial, for the restoration of the intestinal barrier function in patients suffering from gastrointestinal diseases, such as celiac disease, inflammatory bowel disease, short bowel syndrome, irritable bowel syndrome with diarrhea, and other intestinal barrier function diseases; and IMU-381, which is in preclinical trial, for the treatment of gastrointestinal diseases. Immunic, Inc. was founded in 2016 and is headquartered in New York, New York.

Company website: imux.com

IMUX insider activity at a glance

FilingIQ has scored 40 insider transactions for IMUX since Dec 2, 2019. The most recent filing in our index is dated May 22, 2026.

Across the full history, 29 open-market purchases and 5 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on IMUX insider trades is 57.0/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live IMUX trades on FilingIQ Raw filings on SEC EDGAR

Latest IMUX Form 4 filings

Whaley Glenn Chief Financial Officer

P Jun 3, 2025

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Other Healthcare tickers with recent insider activity

UTHR 1,165

UNITED THERAPEUTICS Corp

APLS 275

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

GH 191

Guardant Health, Inc.

KYMR 178

Kymera Therapeutics, Inc.

First Tracks Biotherapeutics, Inc.

Frequently asked

How many insider trades does FilingIQ track for IMUX?: FilingIQ tracks 40 Form 4 insider transactions for IMUX (IMMUNIC, INC.), covering filings from Dec 2, 2019 onwards. 2 of those were filed in the last 90 days.
Are IMUX insiders net buyers or net sellers?: Across the full Form 4 history for IMUX, 29 transactions (73%) were open-market purchases and 5 (13%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does IMUX insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is IMUX in?: IMMUNIC, INC. (IMUX) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $203.91M.

Methodology & sources

Every IMUX insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.